thats my subtle point with you all....ISIS with its fatal flaws(post 182 from your board) hasnt relied on price dilution for its capital...maybe CYGX has flawed management.....
Wow, some great posts here. This board has really become productive. Neo43 who wrote post #5486 talks about ISIS and how well they are doing and how many products they have in the pipeline and in clinical tests. It almost doesn't seem real. I am not a scientist but I feel our science is better than ISIS. Our business plan must be the problem. The only suggestion I have for CYGX is to get a headhunter and try and hire some of the financial advisors away from ISIS and have them give us a some sound financial advice. Their plan clearly has preformed better than ours and they did it without dilution.
The meeting tomorrow I hope will answer some of our concerns and the stock will rise again.
Market Data 
Markets 
AI
